CCN6 and Osteopenia: Considering the results of the present study indicating that CCN6 suppresses osteoclast formation by inhibiting the RANKL signaling pathway, the phenotype of osteopenia seen in patients with progressive pseudorheumatoid dysplasia may at least in part be due to the excessive osteoclast formation by loss-of-function mutations in CCN6.